92 filings
Page 5 of 5
8-K
3ux1n
23 Jul 18
Mersana Therapeutics Announces Partial Clinical Hold for XMT-1522 Clinical Trial
5:09pm
8-K
3hog5d444nazs al
29 Jun 18
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
ynlquty 4o2wj
14 May 18
Mersana Therapeutics Announces First Quarter 2018 Financial Results and Provides Business Updates
4:08pm
8-K
jmwzu vu6drxjpp96w
10 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
1ykwjx3z8s
28 Mar 18
Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
12:00am
8-K
4a6u5oyocn7jau
19 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
s5hloox
12 Mar 18
Mersana Appoints David A. Spellman as Chief Financial Officer
12:00am
8-K
cn3dokddf84tb1bgbko
2 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
05a1k93riuuy0ed3
9 Nov 17
Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates
12:00am
8-K
rxz nyemkl3jx
6 Sep 17
Mersana Appoints Lawrence M. Alleva to Board of Directors
12:00am
8-K
ot3a1x53
11 Aug 17
Mersana Announces Second Quarter 2017 Financial Results and Provides Business Updates
12:00am
8-K
4iu16doug9e ta
10 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am